- BRCA1 and BRCA2 - pathologist's starting kit2016 | Second Faculty of Medicine
- Novel complex genomic rearrangement of the BRCA1 gene2008 | First Faculty of Medicine
- Testing of mutations in BRCA1 and BECA2 genes in tumor tissues - possibilities and limitations2016 | Faculty of Medicine in Hradec Králové
- Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically treated patients with non-small cell lung cancer2014 | Faculty of Medicine in Pilsen
- Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers2016 | First Faculty of Medicine
- Long-term BRCA1 down-regulation by small hairpin RNAs targeting the 3' untranslated region2008 | First Faculty of Medicine
- Detection of germ line mutations in the BRCA1 gene by the protein truncation test.1999 | Faculty of Physical Education and Sport
- Options and consequences of genetic testing in patients with high risk of breast and ovarian cancer due to BRCA1 and BRCA2 mutations2015 | Faculty of Medicine in Pilsen
- Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum2016 | First Faculty of Medicine, Second Faculty of Medicine
- Preservation of fertility in young patients with breast cancer, including BRCA1, BRCA2 mutation carriers2023 | First Faculty of Medicine
- Recommendations for follow-up of cancer patients and healthy carriers with BRCA1 or BRCA2 mutations2003 | Faculty of Physical Education and Sport
- Options of prevention in BRCA1 and BRCA2 mutation carriers2011 | First Faculty of Medicine
- Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene2010 | First Faculty of Medicine
- Role of single nucleotide polymorphisms and haplotypes in BRCA1 in breast cancer: Czech case-control study2007 | First Faculty of Medicine
- BRCA1 and BRCA: Genetic testing and what next - Commentary2002 | Publication without faculty affiliation
- Screening of population specific mutaqtions in BRCA1 genePublication without faculty affiliation
- Recommendations for follow-up of cancer patients and healthy carriers with BRCA1 or BRCA2 mutations2003 | First Faculty of Medicine
- Repeat chemosensitivity of epithelial ovarian carcinoma in a BRCA1 mutation carrier to paclitaxel/platinum combination chemotherapy2009 | Faculty of Medicine in Hradec Králové
- Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers2010 | First Faculty of Medicine
- Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction2010 | First Faculty of Medicine
- The role of BRCA1 and BRCA2 genes in breast cancer developmentPublication without faculty affiliation
- Inactivation of BRCA1, BRCA2 and p53 genes in sporadic ovarian cancer2008 | First Faculty of Medicine
- Inactivation of BRCA1, BRCA2 and p53 genes in sporadic ovarian cancerPublication without faculty affiliation
- Detection and occurrence of BRCA1 gene mutation in patients with carcinoma of the breast and ovary2003 | First Faculty of Medicine
- Role of somatic mutations in BRCA1 and BRCA2 genes in sporadic cancer developmentPublication without faculty affiliation
- Mutation analysis of BRCA1 and BRCA2 genes in the hereditary breast and ovarian cancerPublication without faculty affiliation
- Olaparib - the first PARP inhibitor in the treatment of malignant tumors2015 | First Faculty of Medicine
- System of in vitro analysis of BRCA1 sequence variants in patients with hereditary breast cancerPublication without faculty affiliation
- Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA22023 | First Faculty of Medicine
- Repeat chemosensitivity of epithelial ovarian carcinoma in a BRCA1 mutation carrier to paclitaxel/platinum combination chemotherapy2009 | First Faculty of Medicine